Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices-Reference-Cited by-同舟云学术

Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices

Published:2023-11 Issue: Volume:391 Page:131259
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Chavali Sanjay,Barua Sumita,Adji Audrey,Robson Desiree,Raven Lisa M.,Greenfield Jerry R.,Eckford Hunter,Macdonald Peter S.,Hayward Christopher S.,Muthiah Kavitha

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N. Engl. J. Med.,2019

2. Cardiovascular and renal outcomes with Empagliflozin in heart failure;Packer;N. Engl. J. Med.,2020

3. A fully magnetically levitated left ventricular assist device — final report;Mehra;N. Engl. J. Med.,2019

4. Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium;Kormos;J. Heart Lung Transplant.,2020

5. Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus;Cagliostro;Am Heart J Plus Cardiol Res Pract.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation;JHLT Open;2024-08

2. The safety of sodium glucose transporter 2 inhibitors and trends in clinical and hemodynamic parameters in patients with left ventricular assist devices;Artificial Organs;2024-02-26